Evidence map›Paper›PMID 35113777›Full record

SynthesisHuman vaccines & immunotherapeutics2022

The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review.

Ibrahim Mohammed, Areej Nauman, Pradipta Paul, Sanjith Ganesan, Kuan-Han Chen, Syed Muhammad Saad Jalil, Shahd H Jaouni, Hussam Kawas, Wafa A Khan, Ahamed Lazim Vattoth and 4 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Human vaccines & immunotherapeutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 248 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
248citing papers in PubMed, 12 pooled it
37.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

248 citing papers in PubMed, 12 syntheses or guidelines pooled it, 388 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

188 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Ibrahim MohammedWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.
Areej NaumanWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.
Pradipta PaulWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.ORCID 0000-0001-6283-1596
Sanjith GanesanWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.
Kuan-Han ChenWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.
Syed Muhammad Saad JalilWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.
Shahd H JaouniWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.
Hussam KawasWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.
Wafa A KhanWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.
Ahamed Lazim VattothWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.
Yasmeen Alavi Al-HashimiWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.
Ahmed FaresWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.
Rached ZeghlacheWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.ORCID 0000-0002-8243-7438
Dalia ZakariaWeill Cornell Medicine Qatar, Qatar Foundation, Education City, Doha, Qatar.ORCID 0000-0001-9020-0038
Weill Cornell Medical College in Qatar · QA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the relatively rapid development of the COVID-19 pandemic, vaccine development has become crucial for limiting disease transmission. The accelerated growth in the approved COVID-19 vaccines has sparked concerns about their efficacies which have been assessed by many studies. This systematic review compares the efficacy and effectiveness of seven COVID-19 vaccines. A comprehensive systematic literature search was performed using several databases to identify studies reporting the effectiveness or the efficacy of the vaccines. Only 42 studies met our inclusion criteria, which revealed that the COVID-19 vaccines have successfully reduced the rates of infections, severity, hospitalization, and mortality among the different populations. The full-dose regimen of the Pfizer/BioNTech vaccine is the most effective against infections with the B.1.1.7 and B.1.351 variants. Despite of the high effectiveness of some of the COVID-19 vaccines, more efforts are required to test their effectiveness against the other newly emerging variants.

Indexed as

COVID-19COVID-19 VaccinesHospitalizationHumansPandemicsSARS-CoV-2COVID-19 VaccinesCOVID-19effectivenessefficacyvaccine

Identifiers

PMID35113777
PMCPMC8862168
OpenAlexW4210449375

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.